Long COVID research risks losing momentum – we need a moonshot

Lisa McCorkell () and Michael J. Peluso ()

Nature, 2023, vol. 622, issue 7983, 457-460

Abstract: Investing US$1 billion every year for the next ten years into long COVID research could improve the lives of millions and save trillions in economic costs.

Keywords: SARS-CoV-2; Diseases; Medical research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-03225-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:622:y:2023:i:7983:d:10.1038_d41586-023-03225-w

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-03225-w

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().